New Jersey · 2026-2027 Regular Session · Bill
A 5359: Classifies 7 Hydroxymitragynine as Schedule I drug.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 5359 is a bill introduced in the New Jersey House on September 10, 2026. According to its official title, it concerns: Classifies 7 Hydroxymitragynine as Schedule I drug. Primary sponsor: Mike Inganamort (Republican), Clinton Calabrese (Democratic), Cody Miller (Democratic). It lists 1 additional sponsor. Most recent recorded action (September 10, 2026): Introduced, Referred to Assembly Judiciary Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 2 · Republican 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Mike Inganamort | Primary sponsor | Republican | House | 24 |
| Clinton Calabrese | Primary sponsor | Democratic | House | 36 |
| Cody Miller | Primary sponsor | Democratic | House | 4 |
| Gerry Scharfenberger | Co-sponsor | Republican | House | 13 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Introduced, Referred to Assembly Judiciary Committee